JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
SEPARATE ACCOUNTS A, S, AND UV
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
SEPARATE ACCOUNT B
Supplement dated August 8, 2025 to the Statutory Prospectuses,
Updating Summary Prospectuses, and Initial Summary Prospectuses,
dated April 28, 2025
Changes to Variable Investment Options
This Supplement is intended for distribution with the Statutory Prospectuses, Updating Summary Prospectuses, and Initial Summary Prospectuses, as applicable, (each a “prospectus”) dated April 28, 2025 for variable life insurance contracts issued by John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York, as applicable. The affected prospectuses belong to the following policies:
| Majestic Accumulation Variable Universal Life 2019 |
Majestic Variable Estate Protection | |
| Majestic Accumulation Variable Universal Life 2021 |
Majestic Variable Estate Protection 98 | |
| Majestic Performance Survivorship Variable Universal Life |
Majestic Variable Universal Life | |
| Majestic Performance Variable Universal Life |
Majestic Variable Universal Life 98 | |
| Majestic Survivorship Variable Universal Life 2020 |
Majestic VCOLIX | |
| Majestic Survivorship VULX |
Majestic VULX | |
| Majestic Variable COLI |
Variable Master Plan Plus |
Effective immediately, the “M Large Cap Growth Fund” subadviser listed in the “Appendix: Portfolio’s Available Under the Policy” section of the prospectus is as follows:
| Investment Objective
|
Portfolio and Adviser/Subadviser
|
Current
|
Average Annual Total Returns
| |||||||
| 1-Year
|
5-Year
|
10-Year
| ||||||||
| Seeks to provide long-term capital appreciation.
|
M Large Cap Growth Fund - Series M M Financial Investment Advisers, Inc./Federated MDTA LLC
|
0.58%
|
25.50
|
14.12
|
13.87
| |||||
You should read this supplement together with the prospectus for the contract you purchased and retain both documents for future reference.
Prior to making any investment decisions, you should carefully review your product prospectus and all applicable supplements. In addition, you should review the prospectuses and applicable supplements for the underlying portfolios that we make available as investment options under the policies. The prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the portfolios. In the case of any of the portfolios that are operated as feeder funds, you should also review the prospectus for the corresponding master fund. If you need to obtain additional copies of any of these documents, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus.
| VLI ProdSupp VL 08/2025 |
||||||||
| 333-164151 | 333-164154 | 333-164169 | 333-153252 | 333-132905 | ||||
| 333-164152 | 333-164164 | 333-131299 | 333-233648 | 333-148992 | ||||
| 333-164153 | 333-164163 | 333-148991 | 333-236447 | 333-151631 | ||||
| 333-164156 | 333-164165 | 333-151630 | 333-254211 | 333-153253 | ||||
| 333-235397 |
||||||||